<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-20T01:44:52Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/7561" metadataPrefix="edm">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/7561</identifier><datestamp>2023-04-19T08:00:45Z</datestamp><setSpec>com_10259_4365</setSpec><setSpec>com_10259_5086</setSpec><setSpec>com_10259_2604</setSpec><setSpec>com_10259_4363</setSpec><setSpec>com_10259_6185</setSpec><setSpec>com_10259_3591</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>col_10259_4366</setSpec><setSpec>col_10259_4364</setSpec><setSpec>col_10259_6186</setSpec></header><metadata><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:ds="http://dspace.org/ds/elements/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# http://www.europeana.eu/schemas/edm/EDM.xsd">
<edm:ProvidedCHO rdf:about="http://hdl.handle.net/10259/7561">
<dc:creator>Acuña, M. Isabel</dc:creator>
<dc:creator>Rubio Antolin, Ana Rosa</dc:creator>
<dc:creator>Martínez Alonso, Marta</dc:creator>
<dc:creator>Busto Vázquez, Natalia</dc:creator>
<dc:creator>Rodríguez, Ana María</dc:creator>
<dc:creator>Davila Ferreira, Nerea</dc:creator>
<dc:creator>Smythe, Carl</dc:creator>
<dc:creator>Espino Ordóñez, Gustavo</dc:creator>
<dc:creator>García Ruiz, Begoña</dc:creator>
<dc:creator>Domínguez, Fernando</dc:creator>
<dc:date>2022-12</dc:date>
<dc:description>Cancers are driven by multiple genetic mutations but evolve to evade treatments targeting&#xd;
specific mutations. Nonetheless, cancers cannot evade a treatment that targets mitochondria, which&#xd;
are essential for tumor progression. Iridium complexes have shown anticancer properties, but&#xd;
they lack specificity for their intracellular targets, leading to undesirable side effects. Herein we&#xd;
present a systematic study on structure-activity relationships of eight arylbenzazole-based Iridium(III)&#xd;
complexes of type [IrCl(Cp*)], that have revealed the role of each atom of the ancillary ligand in the&#xd;
physical chemistry properties, cytotoxicity and mechanism of biological action. Neutral complexes,&#xd;
especially those bearing phenylbenzimidazole (HL1 and HL2), restrict the binding to DNA and&#xd;
albumin. One of them, complex 1[C,NH-Cl], is the most selective one, does not bind DNA, targets&#xd;
exclusively the mitochondria, disturbs the mitochondria membrane permeability inducing proton&#xd;
leak and increases ROS levels, triggering the molecular machinery of regulated cell death. In&#xd;
mice with orthotopic lung tumors, the administration of complex 1[C,NH-Cl] reduced the tumor&#xd;
burden. Cancers are more vulnerable than normal tissues to a treatment that harnesses mitochondrial&#xd;
dysfunction. Thus, complex 1[C,NH-Cl] characterization opens the way to the development of new&#xd;
compounds to exploit this vulnerability</dc:description>
<dc:format>application/pdf</dc:format>
<dc:identifier>http://hdl.handle.net/10259/7561</dc:identifier>
<dc:language>eng</dc:language>
<dc:publisher>MDPI</dc:publisher>
<dc:title>Targets, Mechanisms and Cytotoxicity of Half-Sandwich Ir(III) Complexes Are Modulated by Structural Modifications on the Benzazole Ancillary Ligand</dc:title>
<dc:type>info:eu-repo/semantics/article</dc:type>
<edm:type>TEXT</edm:type>
</edm:ProvidedCHO>
<ore:Aggregation rdf:about="http://hdl.handle.net/10259/7561#aggregation">
<edm:aggregatedCHO rdf:resource="http://hdl.handle.net/10259/7561"/>
<edm:dataProvider>RIUBU. Repositorio Institucional de la Universidad de Burgos</edm:dataProvider>
<edm:isShownAt rdf:resource="http://hdl.handle.net/10259/7561"/>
<edm:isShownBy rdf:resource="https://riubu.ubu.es/bitstream/10259/7561/1/Acu%c3%b1a-Cancers_2022.pdf"/>
<edm:object rdf:resource="https://riubu.ubu.es/bitstream/10259/7561/4/Acu%c3%b1a-Cancers_2022.pdf.jpg"/>
<edm:provider>Hispana</edm:provider>
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
</ore:Aggregation>
<edm:WebResource rdf:about="https://riubu.ubu.es/bitstream/10259/7561/1/Acu%c3%b1a-Cancers_2022.pdf">
<edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
</edm:WebResource>
</rdf:RDF></metadata></record></GetRecord></OAI-PMH>